Brian Wolpin, MD, MPH, is Director of the Hale Family Research Center, Director of the Gastrointestinal Cancer Center, Co-Director of the Pancreas and Biliary Tumor Center, and the Robert T. and Judith B. Hale Chair in Pancreatic Cancer at Dana-Farber Cancer Institute. He is Associate Professor of Medicine at Harvard Medical School.
Dr. Wolpin’s clinical practice involves the care of patients with gastrointestinal cancers, with a particular focus on pancreatic cancer. He has held several leadership positions related to clinical expertise, including membership on the Alliance/CALGB Gastrointestinal Cancer Committee and Pancreas Cancer Working Group, National Comprehensive Cancer Network Guidelines Committee for Pancreatic Adenocarcinoma, and Vice Chair of the National Cancer Institute Pancreas Task Force.
Dr. Wolpin’s research program is focused on understanding the factors that cause pancreatic ductal adenocarcinoma to develop and grow. These studies involve evaluation of mutations in both heritable and non-heritable genes in hundreds to thousands of subjects. His research has been funded by the National Cancer Institute, Howard Hughes Medical Institute, Lustgarten Foundation, Pancreatic Cancer Action Network, Stand Up To Cancer, ASCO Conquer Cancer Foundation, and U.S. Department of Defense.
Dr. Wolpin obtained his Doctor of Medicine from Harvard Medical School and completed a residency in internal medicine at Brigham and Women’s Hospital. He completed fellowship training in medical oncology at Dana-Farber and returned to Brigham and Women’s Hospital to serve as Chief Medical Resident. Subsequently, he received a Master of Public Health from Harvard School of Public Health.